Prospective cohort analysis demonstrates that higher triglyceride glucose-body mass index increases cardiovascular disease risk in menopausal women, indicating its role as a key biomarker.
The association between the triglyceride glucose-body mass (TyG-BMI) index and cardiovascular disease (CVD) risk in postmenopausal women remains unclear. This study examines this association in Chinese menopausal women to develop targeted risk assessment tools. Data from the 2011 and 2020 China Health and Retirement Longitudinal Study (CHARLS) included menopausal women aged ≥45 years. Multivariable logistic regression models assessed the association between TyG-BMI and CVD. Restricted cubic spline (RCS) regression tested nonlinearity, and stratified analyses evaluated effect modification. Among 2405 participants, 609 (25.32 %) developed CVD. Each interquartile TyG-BMI (49.10) increase raised CVD risk by 28 % (OR = 1.28; 95 % CI: 1.07-1.53). A linear dose-response relationship existed for CVD (P-trend <0.05; P-nonlinearity >0.05). Marital status modified the association (P-interaction = 0.035), with no significant interactions in other subgroups. For CVD prediction, TyG-BMI (AUC = 0.645) outperformed TyG (AUC = 0.622). Our study demonstrates a significant association between TyG-BMI and the risk of CVD in postmenopausal women, supporting its utility as a valuable biomarker for enhancing primary prevention and management strategies in this population.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: